The role of distinct co-mutation patterns with TP53 mutation in immunotherapy for NSCLC
TP53 mutations was reported to be correlated to the efficacy of program death-1 (PD-1) and program death ligand-1 (PD-L1). The role of co-mutations of TP53 with other recurrently mutated genes in outcome of anti-PD-(L)1 treatment for non-small cell lung cancer (NSCLC) is unknown. Here we mined a pre...
Збережено в:
| Автори: | , , , , |
|---|---|
| Формат: | Artigo |
| Мова: | Inglês |
| Опубліковано: |
KeAi Communications Co., Ltd.
2022-01-01
|
| Серія: | Genes and Diseases |
| Предмети: | |
| Онлайн доступ: | http://www.sciencedirect.com/science/article/pii/S2352304220300532 |
| Теги: |
Немає тегів, Будьте першим, хто поставить тег для цього запису!
|